Lucindo José Quintans-Júnior Selected Research

Lucindo José Quintans-Júnior Research Topics

Disease

10	COVID-19 01/2022 - 01/2020
9	Inflammation (Inflammations) 06/2022 - 10/2011
7	Pain (Aches) 06/2022 - 10/2012
7	Hyperalgesia 12/2019 - 10/2014
5	Edema (Dropsy) 02/2022 - 03/2013
4	Infections 01/2021 - 10/2011
3	Granuloma 05/2020 - 01/2014
2	Hypertrophy 02/2022 - 11/2020
2	Cardiomegaly (Heart Hypertrophy) 11/2020 - 01/2018
2	Fibrosis (Cirrhosis) 11/2020 - 01/2020
2	Hypertension (High Blood Pressure) 11/2020 - 02/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2018
2	Fibromyalgia (Fibrositis) 09/2020 - 07/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2020 - 12/2017
2	Chronic Pain 12/2019 - 05/2019
2	Cancer Pain 05/2019 - 09/2018
2	Neoplasms (Cancer) 09/2018 - 01/2014
2	Epilepsy (Aura) 02/2016 - 01/2015
1	Erythema 06/2022
1	Joint Diseases (Joint Disease) 06/2022
1	Knee Osteoarthritis 06/2022
1	Arthralgia (Joint Pain) 06/2022
1	Osteoarthritis 06/2022
1	Cardiotoxicity 02/2022
1	Necrosis 02/2022
1	Myocardial Infarction 02/2022
1	Tachycardia (Tachyarrhythmias) 02/2022
1	Parkinsonian Disorders (Parkinsonism) 11/2021
1	Cytokine Release Syndrome 11/2020
1	Chronic Disease (Chronic Diseases) 09/2020
1	Cognitive Dysfunction 09/2020
1	Musculoskeletal Pain 09/2020
1	Coronavirus Infections 08/2020
1	Melanoma (Melanoma, Malignant) 07/2020

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2022 - 10/2014
6	CyclodextrinsIBA 11/2021 - 11/2016
6	CarrageenanIBA 05/2020 - 03/2013
5	AntioxidantsIBA 06/2022 - 12/2017
5	Pharmaceutical PreparationsIBA 06/2022 - 01/2013
5	Monoterpenes (Monoterpenoids)IBA 05/2020 - 03/2013
5	Analgesics (Analgesic Drugs)IBA 05/2019 - 10/2012
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
3	EnzymesIBA 06/2022 - 12/2017
3	Biological ProductsIBA 06/2022 - 09/2014
3	myrtenolIBA 11/2021 - 01/2018
3	Antiviral Agents (Antivirals)IBA 10/2021 - 08/2020
3	carvacrolIBA 11/2020 - 12/2017
3	linaloolIBA 07/2020 - 11/2016
3	Acetic Acid (Vinegar)FDA LinkGeneric 12/2017 - 03/2013
3	Dinoprostone (PGE2)FDA Link 10/2016 - 01/2014
2	Superoxide DismutaseIBA 06/2022 - 01/2020
2	CatalaseIBA 06/2022 - 01/2020
2	Peroxidase (Myeloperoxidase)IBA 06/2022 - 12/2017
2	hesperetinIBA 06/2022 - 01/2017
2	Therapeutic UsesIBA 06/2022 - 10/2011
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2022 - 11/2020
2	Peptides (Polypeptides)IBA 01/2022 - 10/2016
2	AntigensIBA 11/2021 - 10/2021
2	Dextrans (Dextran)FDA Link 05/2020 - 05/2020
2	FlavonoidsIBA 02/2020 - 01/2015
2	Volatile Oils (Essential Oils)IBA 01/2020 - 03/2017
2	Dopamine (Intropin)FDA LinkGeneric 10/2016 - 01/2015
1	LipidsIBA 06/2022
1	HydrogelsIBA 06/2022
1	ecallantide FDA Link 01/2022
1	Noscapine (Narcotine)IBA 01/2022
1	icatibantIBA 01/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	Receptor for Advanced Glycation End ProductsIBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	AntibodiesIBA 01/2022
1	lanadelumabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	BradykininIBA 01/2022
1	Immunoglobulin G (IgG)IBA 11/2021
1	Immunoglobulin M (IgM)IBA 11/2021
1	Reserpine (Serpasil)FDA Link 11/2021
1	GangliosidesIBA 10/2021
1	Antimalarials (Antimalarial Agents)IBA 10/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2021
1	VaccinesIBA 04/2021
1	candesartanIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	losartan carboxylic acidIBA 01/2021
1	eprosartan (Teveten)FDA Link 01/2021
1	olmesartanIBA 01/2021
1	Telmisartan (Micardis)FDA Link 01/2021
1	azilsartanIBA 01/2021
1	Valsartan (Vals)FDA Link 01/2021
1	FarnesolIBA 11/2020
1	Antiparasitic Agents (Antiparasitics)IBA 11/2020
1	Antihypertensive Agents (Antihypertensives)IBA 11/2020
1	Antineoplastic Agents (Antineoplastics)IBA 11/2020
1	Anti-Anxiety Agents (Anxiolytics)IBA 09/2020
1	NanocapsulesIBA 07/2020

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2016
4	Traditional Medicine (Folk Remedies) 06/2022 - 02/2010
1	Artificial Respiration (Mechanical Ventilation) 10/2021
1	Length of Stay 10/2021
1	Drug Therapy (Chemotherapy) 07/2020